KIT and leukemia: Puttini et al. investigated the suppressive effects of bosutinib and imatinib on growth of leukemia cells expressing Bcr-Abl, Ba/F3 cells expressing PDGFRβ, and gastrointestinal stromal tumor cells expressing c-KIT, and calculated their IC50 values [26].